Dutasteride (trade name Avodart by GlaxoSmithKline) is a dual 5-a reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone (DHT). Dutasteride is FDA approved for treatment of benign prostatic hyperplasia (BPH) and is also prescribed off-label for treatment of male pattern baldness (MPB).

Dutasteride (trade name Avodart by GlaxoSmithKline) is a dual 5-a reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone (DHT). Dutasteride is FDA approved for treatment of benign prostatic hyperplasia (BPH) and is also prescribed off-label for treatment of male pattern baldness (MPB).